{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075234","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.449440+00:00","generated_at":"2026-06-01T01:07:27.392939+00:00","sec_items":["1.01","3.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"TriSalus completes warrant exchange; 78.9% of public warrants tendered; warrant amendment enacted","bullets":["6,533,614 Public Warrants (78.89%) tendered for 0.30 shares each; settlement by July 1, 2024.","504,685 Private Placement Warrants (10.23%) and 0 Working Capital Warrants tendered.","Warrant Amendment approved for Public Warrants; allows company to force conversion of remaining warrants at 0.27 shares (10% discount).","Registration statement on Form S-4 declared effective by SEC on June 25, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075234","json":"https://secwatch.observer/filing/0001104659-24-075234.json","markdown":"https://secwatch.observer/filing/0001104659-24-075234.md","text":"https://secwatch.observer/filing/0001104659-24-075234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924075234/0001104659-24-075234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924075234/tm2418344d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:07:27.392939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}